The ASX-listed biotech companies hoping to improve the lives of cancer patients

Cancer is estimated to cost nearly US$1 trillion worldwide every year, but a small group of ASX biotech stocks is working to change that.

Related Keywords

Australia ,United States ,Australian ,James Campbell ,Gary Phillips ,Tedros Adhanom Ghebreyesus ,Lifesciences Webinar ,John Lambert ,Imugene Ltd ,Emory University Winship Cancer Institute ,University Of Florida ,Us National Cancer Institute ,World Health Organisation ,Henry Ford Cancer Institute ,Columbia University Irving Cancer Research Center ,Memorial Sloan Kettering Cancer Center ,Proactive Lifesciences Webinar ,Australian Government ,